发明名称 |
ADENYLYL CYCLASE-ASSOCIATED PROTEIN (CAP1) AND USES THEREOF AS A TARGET FOR IMMUNO-MODULATION |
摘要 |
The present invention relates to the use of Adenylyl Cyclase-Associated Protein (CAP1) as a target for immuno-modulation. More specifically, the invention relates to the use of compounds that interact and bind CAP1, specifically, anti-CAP1 antibodies, and/or to CAP1 molecule or any fragments thereof, for the treatment of immune-related disorders by modulation of the Th1/Th2 balance. The invention further provides screening method for immuno-modulatory compounds that interact with CAP1.
|
申请公布号 |
US2012014973(A1) |
申请公布日期 |
2012.01.19 |
申请号 |
US201013257633 |
申请日期 |
2010.03.21 |
申请人 |
NAPARSTEK YAAKOV;MOALLEM ELI;PROTAB LTD. |
发明人 |
NAPARSTEK YAAKOV;MOALLEM ELI |
分类号 |
A61K39/395;A61K38/17;A61P29/00;A61P37/02;C07K14/47;C07K16/18;G01N33/566 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|